Home Healthcare Market- Growth and Opportunity Analysis 2022-2026
                     MarketsandMarkets 
Presents
Home Healthcare Market worth $298.2 billion by 2026
https://www.marketsandmarkets.com/Market-Reports/home-healthcare-equipment-market-
696.html
The report "Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, 
Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), 
Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2026", size is projected 
to reach USD 298.2 billion by 2026 from USD 198.9 billion in 2021, at a CAGR of 8.4% during the 
forecast period.
Browse 419 market data Tables and 52 Figures spread through 438 Pages and in-depth TOC on 
"Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, 
Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), 
Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2026"
Rapid growth in the elderly population, the rising incidence of chronic diseases, the growing 
need for cost-effective healthcare delivery due to the increasing healthcare costs, and 
technological advancements of home care devices are the major factors driving the growth of 
this market.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=696
Objectives of the Study:
• the dialysis equipment segment accounted for the largest share of the home healthcare 
therapeutic products
• The diabetes indication segment is expected to grow at the highest CAGR
By indication type, the global home healthcare market is segmented into cancer, 
respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, 
pregnancy, wound care, diabetes, hearing disorders, and other indications. The 
diabetes segment is expected to register the highest CAGR during the forecast 
period. The increasing number of diabetic patients mainly drives growth in this 
market. Moreover, monitoring blood sugar at home helps arrive at an overall 
diabetes treatment plan and aids in managing the medications for blood sugar, diet, 
and exercise.
• North America was the largest regional
Speak to Analyst: https://www.marketsandmarkets.com/
This report categorizes the home healthcare market into the following segments and subsegments:
By Product
• Testing, Screening, & Monitoring Products
• Therapeutic Products
• Mobility Care Products
By Service
• Skilled Nursing Services
• Rehabilitation Therapy Services
• Hospice and Palliative Care Services
• Unskilled Care Services
• Respiratory Therapy Services
• Infusion Therapy Services
• Pregnancy Care Services
By Indication
• Cardiovascular Disorders & Hypertension
• Diabetes
• Respiratory Diseases
• Pregnancy
• Mobility Disorders
• Hearing Disorders
• Cancer
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)
The global home healthcare market is highly fragmented. The prominent players in the 
global home healthcare industry include Fresenius SE & Co. KGaA, GE Healthcare, Linde 
plc, F. Hoffmann-La Roche Ltd, A&D Company, BAYADA Home Health Care, Invacare 
Corporation, Abbott, Amedisys, ResMed, LHC Group, Inc., OMRON Corporation, 
Koninklijke Philips N.V., Drive DeVilbiss Healthcare, Hamilton Medical, Sunrise Medical, 
Roma Medical, Caremax Rehabilitation Equipment Co., Ltd, Vitalograph and Among 
others
Companies Insight
Abbott (US) is one of the major players of blood glucose monitor in the home healthcare market 
with a share of 8.4% in 2020. The company has a strong product portfolio in the home 
healthcare market, especially blood glucose meters. It has a strong geographic presence across 
the globe and invests a significant amount of its revenue in R&D. In FY 2020, Abbott invested 
6.9% of its total revenue in R&D.
F. hoffmann-la roche ltd (Switzerland) is one of the prominent players of blood glucose monitor 
in the home healthcare market with a share of 3.6% in 2020. Roche is known for its strong 
portfolio in diagnostics and is the frontrunner in diabetes management. The diabetes care 
product portfolio offers an integrated, collaborative, and personalized approach that aims to 
determine the optimal therapy for each person with diabetes. The company invests a significant 
part of its revenue in R&D. It has constantly increased its R&D investments to accelerate 
innovative product development. In FY 2020, the company invested about USD 13.8 billion in 
R&D, which witnessed an increase of 7.9% as compared to FY 2019. These investments were 
aimed at discovering, testing, and developing new products and improving existing products
GE Healthcare (US) is one of the prominent players of blood glucose monitor in the home 
healthcare market with a share of 3.0% in 2020. its expertise in medical imaging and information 
technologies, medical diagnostics, patient monitoring systems, drug discovery, 
biopharmaceutical manufacturing technologies, and life care solutions.
Contact Us
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road, Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
Press release: 
https://www.marketsandmarkets.com/PressReleases/home-healthcar
e.asp
Research insights: 
https://www.marketsandmarkets.com/ResearchInsight/home-healthc
are-equipment-market.asp
About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche 
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. 
Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 
companies as clients. Almost 75,000 top officers across eight industries worldwide 
approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high 
growth markets following the "Growth Engagement Model – GEM". The GEM aims at 
proactive collaboration with the clients to identify new opportunities, identify most 
important customers, write "Attack, avoid and defend" strategies, identify sources of 
incremental revenues for both the company and its competitors. MarketsandMarkets™ 
now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, 
emerging companies, innovators, strategic players) annually in high growth emerging 
segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies 
this year for their revenue planning and help them take their innovations/disruptions 
early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, 
"RT" connects over 200,000 markets and entire value chains for deeper understanding 
of the unmet insights along with market sizing and forecasts of niche markets.